Insider Selling: Docusign (NASDAQ:DOCU) Director Sells $1,222,200.00 in Stock

Docusign Inc. (NASDAQ:DOCU) Director Peter Solvik sold 15,000 shares of Docusign stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the completion of the transaction, the director directly owned 135,253 shares in the company, valued at $11,020,414.44. This trade represents a 9.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Docusign Price Performance

Shares of NASDAQ:DOCU opened at $84.59 on Friday. The company’s 50 day simple moving average is $76.39 and its 200 day simple moving average is $79.30. The stock has a market capitalization of $17.01 billion, a price-to-earnings ratio of 63.60, a price-to-earnings-growth ratio of 4.46 and a beta of 1.02. Docusign Inc. has a 1 year low of $57.58 and a 1 year high of $107.86.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.08. The business had revenue of $800.64 million for the quarter, compared to analysts’ expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period last year, the firm posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a share repurchase plan on Thursday, June 5th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

A number of brokerages recently issued reports on DOCU. UBS Group set a $95.00 price objective on shares of Docusign in a research note on Friday, September 5th. Royal Bank Of Canada lifted their price objective on shares of Docusign from $90.00 to $95.00 and gave the company a “sector perform” rating in a research note on Friday, September 5th. Zacks Research raised shares of Docusign from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research note on Friday, September 5th. Finally, Evercore ISI boosted their target price on shares of Docusign from $90.00 to $92.00 and gave the stock an “in-line” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $94.14.

Hedge Funds Weigh In On Docusign

A number of hedge funds have recently modified their holdings of DOCU. Norges Bank acquired a new position in shares of Docusign during the second quarter worth $140,987,000. Wellington Management Group LLP lifted its holdings in shares of Docusign by 372.5% during the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company’s stock worth $148,714,000 after purchasing an additional 1,440,269 shares during the period. Duquesne Family Office LLC bought a new stake in Docusign during the first quarter valued at $87,477,000. Pacer Advisors Inc. boosted its position in Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company’s stock valued at $95,017,000 after acquiring an additional 1,038,962 shares during the last quarter. Finally, Third Point LLC bought a new stake in Docusign during the second quarter valued at $48,681,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.